Muñoz Martín, A. J. http://orcid.org/0000-0001-6977-8249
Gallardo Díaz, E.
García Escobar, I.
Macías Montero, R.
Martínez-Marín, V.
Pachón Olmos, V.
Pérez Segura, P.
Quintanar Verdúguez, T.
Salgado Fernández, M.
Article History
Received: 5 December 2019
Accepted: 5 December 2019
First Online: 24 January 2020
Compliance with ethical standards
:
: AMM reports consulting or advisory role from Celgene, Sanofi, Pfizer, Bristol-Myers Squibb, LEO Pharma, Daiichi Sankyo, Bayer and Halozyme; Speakers’ Bureau from Rovi; Research Funding from Sanofi and LEO Pharma; Travel, Accommodations, Expenses from Celgene, Roche and Merck Serono. Patents, Royalties, Other Intellectual Property: Risk assessment model in venous thromboembolism in patients with cancer. EG reports from the work under consideration for publication Consultant or advisory role from Rovi, Daiichi Sankyo, Techdow, Sanofi, Pfizer and BMS. Speakers’ Bureau from Rovi, Daiichi Sankyo, Leo Pharma and Sanofi. Travel, Accommodations and Expenses from Rovi, Daiichi Sankyo and Leo Pharma. Relevant financial activities outside the submitted work: Consultant or Advisory Role from Bayer, Merck, Ipsen, Novartis, Eisai, EUSA Pharma, Roche, Janssen, Astellas and AstraZeneca. Speakers’ Bureau from Bayer, Pfizer, BMS, Ipsen, Novartis, Eisai, Roche, Astellas, Janssen, Menarini and MSD. Travel, Accommodations and Expenses from Pfizer, Bayer, Ipsen, Roche, Novartis, Eisai, BMS, Pierre Fabre, Astellas, Janssen and Sanofi. Grant support (personal/institutional) from Pfizer, Bayer, Ipsen, Roche, BMS, Astellas, Janssen, Sanofi, Ferrer. IGE reports from the work under consideration for publication, Consultant or Advisory Role from Rovi. Speakers’ Bureau from Rovi and Leo Pharma. Travel, Accommodations and Expenses from Rovi and Leo Pharma. Relevant financial activities outside the submitted work: Travel, Accommodations and Expenses from Roche and Sanofi. RMM has nothing to disclose. VM has nothing to disclose. VPO reports speaker honoraria from Rovi, Leo Pharma and Sanofi; Advisory from daiichi sankyo. PPS reports speaker honoraria from Leo pharma. TQV reports Consulting or Advisory Role from Novartis and Glaxo-Tesaro; Speakers’ Bureau from Rovi, Sanofi, Roche and Pfizer; Travel, Accommodations and Expenses from Roche. MS reports Consultant or Advisory Role from Rovi; Speakers’ Bureau from Rovi and Leo Pharma. Travel, Accommodations and Expenses from Rovi and Leo Pharma. Relevant financial activities outside the submitted work: Consultant or Advisory Role from Merck, Amgen and Celgene; Speakers’ Bureau from Celgene, Servier and Amgen. Travel, Accommodations and Expenses from Roche and Servier. Grant support (personal/institutional) from Mylan and Kern Pharma.
: The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Inform consent is not needed.